Security key
34385P108
- Security type / class
- Equity / Common Stock
- Total 13F shares
- 47,429,426
- Total 13F value
- $137,541,583
- Share change
- +1,271,496
- Put/Call ratio
- 153%
- SEC-reported price per share
- $2.90
- Number of holders
- 72
- Value change
- +$3,894,497
- Number of buys
- 31
- Number of sells
- 27
- Shares outstanding
- 395,567,350
Holder snapshot
7 signals
Open additional details 1 more signal available
Security identity
Names, identifiers, and filing context for this profile.
1 source field
Report period
Q3 2023
Institutions
72
Top holders
10
LAB full security history
Ownership snapshot
Full 13F holder table
Newer quarter: Q2 2026
STANDARD BIOTOOLS INC. SEC filings
STANDARD BIOTOOLS INC. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 34385P108
Recent filing periods:
Ownership snapshot
Top reported holders of LAB - STANDARD BIOTOOLS INC. - Common Stock (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
Caligan Partners LP
Disclosed value leader
Caligan Partners LP
Comparable rows
15/15
Latest evidence
30 Jun 2023
3/4/5
13F
Lead comparable stake: 2.1%
Showing 1-6 of 15 holder rows.
Quick read
Caligan Partners LP leads the comparable SEC ownership view at 2.1%.
15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens Caligan Partners LP's linked filing trail.
Comparable ownership
Top 5
Caligan Partners LP
2.1%
Indaba Capital Management, L.P.
1.9%
Neuberger Berman Group LLC
1.1%
VANGUARD GROUP INC
1%
PRIMECAP MANAGEMENT CO/CA/
0.81%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| Caligan Partners LP |
3/4/5
13F
10%+ Owner · Company
|
2.1%
from 13F
|
$34,539,714
16,265,374 shares
mixed-class rows
|
— | 29 Jun 2023 |
| Indaba Capital Management, L.P. |
13F
Company
|
1.9%
|
$14,371,222
7,446,229 shares
|
— | 30 Jun 2023 |
| Neuberger Berman Group LLC |
13F
Company
|
1.1%
|
$8,694,939
4,505,149 shares
|
— | 30 Jun 2023 |
| VANGUARD GROUP INC |
13F
Company
|
1%
|
$7,609,778
3,942,890 shares
|
— | 30 Jun 2023 |
| PRIMECAP MANAGEMENT CO/CA/ |
13F
Company
|
0.81%
|
$6,216,370
3,220,917 shares
|
— | 30 Jun 2023 |
| MORGAN STANLEY |
13F
Company
|
0.77%
|
$5,875,036
3,044,060 shares
|
— | 30 Jun 2023 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q3 2023
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
72
Shares
47,429,426
Rows available
72
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q3 2023 vs Q2 2023 Across Filers
Q2 2023 holders
65
Q3 2023 holders
72
Holder diff
7
| Investor | Q2 2023 Shares | Q3 2023 Shares | Share Diff | Share Chg % | Q2 2023 value | Q3 2023 value | Value change | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend